X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2026-05-07 | BLTE | Mata Nathan L. | Chief Scientific Officer | S - Sale | $153.21 | -666 | 0 | -100% | -$102,039 | ||||||
2026-05-06 | BLTE | Mata Nathan L. | Chief Scientific Officer | S - Sale | $153.84 | -1,000 | 666 | -60% | -$153,839 | ||||||
2026-05-05 | BLTE | Mata Nathan L. | Chief Scientific Officer | S - Sale | $155.50 | -1,000 | 1,666 | -38% | -$155,502 | ||||||
2026-05-04 | BLTE | Mata Nathan L. | Chief Scientific Officer | S - Sale | $155.64 | -1,000 | 2,666 | -27% | -$155,636 | ||||||
2026-05-01 | BLTE | Mata Nathan L. | Chief Scientific Officer | S - Sale | $155.78 | -1,000 | 3,666 | -21% | -$155,778 | ||||||
2026-04-30 | BLTE | Mata Nathan L. | Chief Scientific Officer | S - Sale | $156.97 | -1,000 | 4,666 | -18% | -$156,973 | ||||||
2026-04-29 | BLTE | Mata Nathan L. | Chief Scientific Officer | S - Sale | $155.82 | -1,000 | 5,666 | -15% | -$155,817 | ||||||
2026-04-28 | BLTE | Mata Nathan L. | Chief Scientific Officer | S - Sale | $159.16 | -1,000 | 6,666 | -13% | -$159,162 | ||||||
2026-04-27 | BLTE | Mata Nathan L. | Chief Scientific Officer | S - Sale | $162.64 | -1,000 | 7,666 | -12% | -$162,641 | ||||||
2026-04-24 | BLTE | Mata Nathan L. | Chief Scientific Officer | S - Sale | $159.56 | -1,000 | 8,666 | -10% | -$159,556 | ||||||
2026-04-23 | BLTE | Mata Nathan L. | Chief Scientific Officer | S - Sale | $166.28 | -1,000 | 9,666 | -9% | -$166,284 | ||||||
2026-04-22 | BLTE | Mata Nathan L. | Chief Scientific Officer | S - Sale | $170.38 | -1,000 | 10,666 | -9% | -$170,384 | ||||||
2026-04-21 | BLTE | Mata Nathan L. | Chief Scientific Officer | S - Sale | $166.00 | -1,000 | 11,666 | -8% | -$166,000 | ||||||
2026-04-20 | BLTE | Mata Nathan L. | Chief Scientific Officer | S - Sale | $163.60 | -1,000 | 12,666 | -7% | -$163,595 | ||||||
2026-04-17 | BLTE | Mata Nathan L. | Chief Scientific Officer | S - Sale | $161.63 | -1,000 | 13,666 | -7% | -$161,630 | ||||||
2026-04-16 | BLTE | Mata Nathan L. | Chief Scientific Officer | S - Sale | $160.38 | -1,000 | 14,666 | -6% | -$160,381 | ||||||
2026-04-15 | BLTE | Mata Nathan L. | Chief Scientific Officer | S - Sale | $168.30 | -1,000 | 15,666 | -6% | -$168,298 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |